Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05321459
Other study ID # AOR 20045
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date November 15, 2023
Est. completion date May 29, 2026

Study information

Verified date February 2024
Source Assistance Publique - Hôpitaux de Paris
Contact Nathalie KUBIS, Md, PhD
Phone +33(0)149958324
Email nathalie.kubis@aphp.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Evaluating the prognosis of comatose patients after cardiac arrest (CA) in the intensive care unit (ICU) remains challenging. It requires a multimodal approach combining standardized clinical examination, serum biomarkers, imaging and classically electrophysiological examinations, (among them auditive evoked potentials or AEP) but none has a sufficient sensitivity/specificity. In a preliminary study, the investigators developed an algorithm from the signal collected with AEP, and generated a probability map to visually classify the participants after the algorithm processing. Participants could be classified either with a good neurological prognosis or with bad neurological prognosis or death. The investigators hypothesize that the "PRECOM" tool, applied blindly to a large prospective multicenter cohort of patients admitted to intensive care for coma in the aftermath of CA will predict neurological prognosis at 3 months with high sensitivity and specificity.


Description:

Evaluating the prognosis of comatose participants after cardiac arrest (CA) in the intensive care unit remains challenging. It requires a multimodal approach combining standardized clinical examination, serum biomarkers, imaging and classically electrophysiological examinations: 1 / the electroencephalogram, bad prognosis assessed when the electroencephalogram (EEG) is discontinuous, areactive, monotone,…), 2 / somesthetic evoked potentials, the absence of the N20 cortical wave has a specificity of poor prognosis of 68-100% and 3 / auditory evoked potentials (AEP), the presence of mismatchnegativity (MMN) would be of good prognosis with a specificity up to 90% but rarely performed in current practice. Routinely, these examinations are sometimes difficult to interpret in sedated participants, in an intensive care unit environment that generates numerous artefacts. Above all, all these techniques require the presence of a neurophysiology unit, with few experts available. In a preliminary study, in collaboration with the applied mathematics laboratory of the ENS (Ecole Normale Supérieure), an algorithm was developed from the signal extracted from AEP. A probability map was generated with a software allowing to visually classify the participants after processing signal by the algorithm in a cluster of points with a high specificity into "good neurological prognosis" and "bad neurological prognosis". Neither artifacts or sedation prevented data analysis. The investigators hypothesize that the "PRECOM" tool, applied blindly to a large prospective multicenter cohort of participants admitted to intensive care for coma in the aftermath of a caridiac arrest will predict the neurological prognosis of participants with high sensitivity and specificity. This tool, carried out during the first week of the coma, will be compared to a standardized procedure used routinely by the participating resuscitators.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date May 29, 2026
Est. primary completion date March 1, 2026
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age above18 years old - Patient affiliated to a French Heath Care Insurance - Admitted in the intensive care unit (ICU) for coma post extra- or intra-hospital cardiac arrest (CA) with shockable or non-shockable rhythm - Persistent coma on day 3 after post CA, defined by the inability to respond to a verbal command in an appropriate manner (motor Glasgow components <3 and ocular <3) and at the time of neurophysiological recordings (D3-D7 ± week -end). Exclusion Criteria: - Decision to limit resuscitation therapies taken by the resuscitation team - Inability to perform the auditory evoked potentials (AEP) (deafness, skin lesion or any condition preventing to record AEP). - Opposition by the trusted person or by the patient once he/she wakes up

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Neurological prognosis
In usual practice, in intensive care unit, evaluating the neurological prognosis of comatose patients after cardiac arrest requires a multimodal approach combining standardized clinical examination, serum biomarkers, imaging and classically electrophysiological examinations (among them auditive evoked potentials or AEP). An algorithm (PRECOM tool) which has been previously developed from the signal extracted from AEP allows to visually classify the patients after processing signal by the algorithm in a cluster of points with a high specificity into "good neurological prognosis" and "bad neurological prognosis". The AEP signals recorded in the 1st and 2nd week of patient inclusion are to be collected by the neurophysiologist. At the end of the patient's participation in the study, these data will be encrypted, anonymized and transmitted to the mathematician to be processed by the PRECOM tool.

Locations

Country Name City State
France APHP Avicenne Hospital - Réanimation médico-chirurgicale Bobigny
France APHP Bichat Hospital -Médecine intensive - réanimation infectieuse Paris
France APHP Cochin Hospital - médecine intensive-réanimation Paris
France APHP HEGP hospital - Réanimation médicale Paris
France APHP Lariboisière Hospital, Clinical Physiology Department Paris
France APHP Laribosière Hospital - Service de Réanimation Médical et Toxicologique Paris
France Delafontaine Hospital - médecine intensive-réanimation Saint-Denis

Sponsors (2)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris Ecole Normale Supérieure de Paris

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Awakening within 3 months Awakening is defined as normal motor activity in response to the 3 instructions for the motor component M of the FOUR score (show your thumb, make the V for victory and show your fist; M = 4). This criterion will be collected by the doctor in charge of the patient at the time of the assessment and will be dated. within 3 months ± 2 weeks after inclusion
Secondary CPC score within 3 months CPC (Cerebral Performance Category) score is performed wether patient is still hospitalized or returned home. It is performed by phone call if patient returned home.
Range of values rates neurological status after cardiac arrest on a scale of 1 to 5 (1 for good cerebral performance up to 5 for brain death).
3 months ± 2 weeks after inclusion
Secondary mRS score within 3 months mRS (Modified Rankin Scale) scores is performed wether patient is still hospitalized or returned home. It is performed by phone call if patient returned home.
mRS (modified Rankin Scale) scale measures degree of disability/dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. Score can be between 0 (no symptoms at all) and 5 (major disability : bedridden, incontinent and requiring constant nursing care and attention).
3 months ± 2 weeks after inclusion
Secondary FOUR score within 3 months FOUR (Full Outline of UnResponsiveness) score is performed only if patient is still hospitalized (being awake or not).
FOUR score is a grading scale for assessing the level of consciousness performed on patients with severe neurologic impairment..It addresses four domains of neurological functioning: Eye response; Motor response ; Brainstem score and Respiratory score.
Score is ranging from 0 to 16 where the lower the score, the greater the coma gravity.
3 months ± 2 weeks after inclusion
Secondary GOSE score within 3 months GOSE (Extended Glasgow Outcome Scale) score is performed wether patient is still hospitalized or returned home.
GOSE score classifies global outcomes in traumatic brain injury survivors. It rates patient status into one of eight categories ranging from 8 (Upper good recovery) to 1 (Dead).
3 months ± 2 weeks after inclusion
Secondary CPC score within 6 months CPC (Cerebral Performance Category) score is performed wether patient is still hospitalized or returned home. It is performed by phone call if patient returned home.
Range of values rates neurological status after cardiac arrest on a scale of 1 to 5 (1 for good cerebral performance up to 5 for brain death).
6 months ± 2 weeks after inclusion
Secondary mRS score within 6 months mRS (Modified Rankin Scale) scores is performed wether patient is still hospitalized or returned home. It is performed by phone call if patient returned home.
mRS (modified Rankin Scale) scale measures degree of disability/dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. Score can be between 0 (no symptoms at all) and 5 (major disability : bedridden, incontinent and requiring constant nursing care and attention).
within 6 months ± 2 weeks after inclusion
Secondary GOSE score within 6 months GOSE (Extended Glasgow Outcome Scale) score is performed wether patient is still hospitalized or returned home.
GOSE score classifies global outcomes in traumatic brain injury survivors. It rates patient status into one of eight categories ranging from 8 (Upper good recovery) to 1 (Dead).
within 6 months ± 2 weeks after inclusion
Secondary Awakening within 6 months ± 2 weeks Awakening is defined as normal motor activity in response to the 3 instructions for the motor component M of the FOUR score (show your thumb, make the V for victory and show your fist; M = 4). This criterion will be collected by the doctor in charge of the patient at the time of the assessment and will be dated. The measurement takes place only if patient is still hospitalized. within 6 months ± 2 weeks after inclusion
Secondary CRS-R score within 6 months CRS-R (Coma Recovery Scale - Revised) is a standardized neurobehavioral assessment measure designed for use in patients with disorders of consciousness. The scale is intented to be used to establish diagnosis, monitor behavioral recovery and predict outcome. It is performed only if patient is still hospitalized.
The total score ranges between 0 (worst) and 23 (best).
within 6 months ± 2 weeks after inclusion
Secondary PRECOM tool - first week of coma Comparison of the ability of the PRECOM tool using clinical and electrophysiological data at inclusion (the first week of coma), to classify patients with good prognosis, poor prognosis and indeterminate prognosis with respect to this same categorization using the usual evaluation criteria performed routinely by participating resuscitations (clinical examination and EEG for all and evoked potentials in addition for some). Inclusion visit (3 to 7 days after cardiac arrest +/- 2 days if week-end)
Secondary PRECOM tool - second week of coma Comparison of the ability of the PRECOM tool using clinical and electrophysiological data the second week of coma, to classify patients with good prognosis, poor prognosis and indeterminate prognosis with respect to this same categorization using the usual evaluation criteria performed routinely by participating resuscitations (clinical examination and EEG for all and evoked potentials in addition for some). One week visit (one week after inclusion visit +/- 2 days)
Secondary PRECOM tool - first and second week of coma Comparison of the ability of the PRECOM tool using combinaison of clinical and electrophysiological data collected both at inclusion and one week later (the first two weeks of coma), to classify patients with good prognosis, poor prognosis and indeterminate prognosis with respect to this same categorization using the usual evaluation criteria performed routinely by participating resuscitations (clinical examination and EEG for all and evoked potentials in addition for some). Inclusion and one week visits
Secondary Awakening - second week of coma Awakening is defined as normal motor activity in response to the 3 instructions for the motor component M of the FOUR score (show your thumb, make the V for victory and show your fist; M = 4). This criterion will be collected by the doctor in charge of the patient at the time of the assessment and will be dated. One week visit (one week after inclusion visit +/- 2 days)
Secondary NSE blood marker Comparison of the ability to predict awakening with the PRECOM tool using the NSE blood marker (neuron- spécific enolase) collected 3 days after cardiac arrest between the patients awakened from the coma and those who are not. 3 days post cardiac arrest
Secondary Glial blood markor Comparison of the ability to predict awakening with the PRECOM tool using the Glial Fibrillary Acidic Protein (GFAP) collected at the inclusion visit between the patients awakened from the coma and those who are not. Inclusion visit (3 to 7 days after cardiac arrest +/- 2 days if week-end)
Secondary Neuronal blood markor Comparison of the ability to predict awakening with the PRECOM tool using the Neurofilament blood marker collected at the inclusion visit between the patients awakened from the coma and those who are not. Inclusion visit (3 to 7 days after cardiac arrest +/- 2 days if week-end)
Secondary Inflammatory blood markor Comparison of the ability to predict awakening with the PRECOM tool using the inflammatory blood markers : Kynurenine and Tryptophan; collected at the inclusion visit between the patients awakened from the coma and those who are not. Inclusion visit (3 to 7 days after cardiac arrest +/- 2 days if week-end)
See also
  Status Clinical Trial Phase
Completed NCT04078815 - End-of-life Practices in 2019 vs. 2014
Completed NCT02816385 - Study of Myocardial Contractility After Cardiac Surgery Under an Anterograde or Retrograde Cardioplegia N/A
Completed NCT02486211 - Amantadine to Speed Awakening After Cardiac Arrest Phase 2
Recruiting NCT02326506 - Evaluation of Drainable Volume Measurements During VA-ELS N/A
Completed NCT00139542 - AED Use in Out-of-Hospital Cardiac Arrest: A New Algorithm Named "One Shock Per Minute" Phase 3
Completed NCT00004560 - Public Access Defibrillation (PAD) Community Trial Phase 3
Completed NCT00000502 - Evaluation of SC-V Versus Conventional CPR Phase 3
Completed NCT03640949 - Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest Phase 2/Phase 3
Completed NCT03310450 - Tour de Borobudur Troponin Study on Predictors and Synergistic Role of MDA and Hs-CRP Levels
Completed NCT02733146 - Histones and Free-plasma DNA After Cardiac Arrest N/A
Withdrawn NCT01082991 - Patient Acuity Rating: a Tool to Prevent In-Hospital Cardiac Arrest Phase 0
Terminated NCT00189423 - ResQ Trial: Impact of an ITD and Active Compression Decompression CPR on Survival From Out-of-Hospital Cardiac Arrest N/A
Completed NCT00172354 - Hydrocortisone in Patients of Out-of-hospital Cardiac Arrest N/A
Completed NCT02858583 - SI + CC Versus 3:1 C:V Ratio During Neonatal CPR N/A
Completed NCT03664557 - Feasibility of REBOA in Refractory Cardiac Arrest N/A
Completed NCT01968148 - Mechanisms of Ultra-acute Hyperglycemia After Successful Resuscitation From Out-of-hospital Cardiac Arrest N/A
Completed NCT00392639 - Clinical and Economical Interest of Endovascular Cooling in the Management of Cardiac Arrest (ICEREA Study) Phase 4
Recruiting NCT06081283 - Antiseizure Medication in Seizure Networks at Early Acute Brain Injury Phase 4
Completed NCT02780050 - Influence of Core Muscles Activation Using Physical Fitness on the Performance of Chest Compression N/A
Withdrawn NCT04287842 - Impact if Desflurane Preconditioning on the Content of the Phospho-GSK-3b in the Rat's Neurons in the Model of I/R Phase 4